NCT04782011

Brief Summary

This is a non blinded two arm cluster randomized control trial, aimed at assessing the feasibility of using the Anatomical Therapeutic Chemical Classification/define Daily Doses system tool to monitor antibiotic use at lower primary levels of care in Uganda.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,406

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 19, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

March 4, 2021

Status Verified

February 1, 2021

Enrollment Period

7 months

First QC Date

February 19, 2021

Last Update Submit

March 1, 2021

Conditions

Keywords

ATC/DDDAntibiotic utilizationLower primary care facilitiesSouthwestern Uganda

Outcome Measures

Primary Outcomes (1)

  • Trends in antibiotic utilization for both the intervention and non intervention arms

    Computation of antibiotic utilization parameters across the different facility levels will be done using the latest version of the ATC/DDD tool. Antibiotic use by clinical condition data will be analyzed using working diagnoses that will be classified into diagnostic groups using the latest version of the International Classification of Diseases, Clinical Modification (ICD-10-CM) diagnosis codes as a guide. Findings of both arms will be compared.

    3 months

Study Arms (2)

ATC/DDD arm

EXPERIMENTAL

The intervention is the introduction of the ATC/DDD including the training of healthcare workers on its importance and usage in monitoring antibiotic use. The unit of intervention will be a health facility. Antibiotic prescriptions and antibiotic utilization records for adult patients (in-patients and ambulatory) from the selected facilities will be enrolled in the study.

Behavioral: ATC/DDD

Control arm

NO INTERVENTION

The health care workers will continue with standard practice. However, the research team will collect data on antibiotic prescriptions and antibiotic utilization for adult patients (in-patients and ambulatory) from the selected facilities. The data will be compared with that of the intervention arm.

Interventions

ATC/DDDBEHAVIORAL

The intervention is the introduction of the ATC/DDD including the training on its importance and usage in monitoring antibiotic use at a given primary care facility.

ATC/DDD arm

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Health facility: The facility will be government owned that receives antibiotics from National Medical Stores using the current schedule and has no ongoing antibiotic use related intervention study.
  • Prescribers: Male and female prescribers at primary care facilities in the selected districts of Mbarara, Bushenyi and Kasese will be recruited. Prescribers with an experience of at least 3 months in antibiotic prescribing and inventory at these facilities will be included in the study. These shall be identified through the in-charges of the respective facilities.
  • Patients: New male and female adult patients (18 years and above) receiving antibiotic medication will be enrolled.
  • Antibiotic utilization records: Antibiotic prescriptions and administration charts for new patients at selected health facilities.

You may not qualify if:

  • Patients: Those who are too sick to cooperate
  • Prescriptions: Ineligible prescriptions and the prescriber cannot be reached for clarifications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanifah Nantongo

Mbarara, Uganda

Location

Study Officials

  • Jackson Mukonzo, PhD

    Makerere University

    STUDY DIRECTOR
  • Vincent Batwala, PhD

    Mbarara University of Science and Technology

    STUDY DIRECTOR

Central Study Contacts

Hanifah Nantongo, MSc

CONTACT

Hanifah Nantongo, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Being a feasibility study that will use patient records, no blinding will be done.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The number of health facilities will be split evenly between the intervention and non intervention arms. These will be randomly selected in the districts of Mbarara, Bushenyi and Kasese.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 4, 2021

Study Start

March 1, 2021

Primary Completion

October 1, 2021

Study Completion

November 1, 2021

Last Updated

March 4, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

I do not intend to share the data

Locations